A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder

Clinical trial NCT00960986 · COMPLETED

Trial details

NCT number: NCT00960986
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2009-08-01
Primary completion: 2011-02-01
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.